Vanda Pharmaceuticals Inc.
METHOD OF TREATMENT WITH TRADIPITANT
Last updated:
Abstract:
Methods of treating an individual experiencing or at risk of experiencing an undesired consequence of opioid use, and of treating an individual who is experiencing or at risk of experiencing a craving for an opioid, as well as the use of the NK-1 receptor antagonist, tradipitant, in the treatment of such an individual are disclosed herein.
Status:
Application
Type:
Utility
Filling date:
6 Jun 2019
Issue date:
29 Jul 2021